Pine bark extract is a polyphenol supplement made from the bark of the French maritime pine tree (Pinus pinaster). The standardized version, sold under the brand name Pycnogenol, has over 160 human clinical trials behind it, more than almost any other natural compound.
People take it for three main reasons: men use it (usually stacked with L-arginine) to support erections and circulation, women use it for hot flashes, period pain, and skin elasticity, and both sexes use it for joint comfort, leg circulation, and general vascular health as they age. The throughline is that it makes blood vessels work better (Endothelial NO / vasodilation), dampens inflammation (NF-κB inhibition), and protects connective tissue. None of the effects are dramatic in the first week, most people notice something around weeks 4-8, and the bigger structural changes accumulate over months.
Deep-dive
Pine bark extract is roughly 65-75% procyanidins, which are oligomeric chains of catechin and epicatechin. The rest is monomeric flavonoids (catechin, taxifolin) and phenolic acids (ferulic, caffeic, gallic acids). The phenolic acids and taxifolin absorb quickly and peak in plasma within a couple of hours. The procyanidins behave differently, gut bacteria break them down into smaller metabolites like δ-(3,4-dihydroxy-phenyl)-γ-valerolactone, which are absorbed slowly and stay in circulation for many hours. This is why the effects build over weeks rather than landing acutely. A pharmacokinetic study in osteoarthritis patients found these metabolites concentrate preferentially in synovial fluid rather than serum, which helps explain why the joint and tissue effects are more robust than the blood markers alone would predict.
Endothelial function and nitric oxide. This is the central mechanism. Pycnogenol stimulates endothelial nitric oxide synthase (eNOS), the enzyme that converts L-arginine into nitric oxide inside the cells lining your blood vessels. More NO means more vasodilation and better blood flow on demand. An ex vivo study showed it relaxed pre-contracted aortic rings in a dose-dependent way, and the effect disappeared when the endothelium was removed, confirming the action is endothelium-dependent. In a crossover trial in 23 patients with stable coronary artery disease, 200 mg/day for 8 weeks improved flow-mediated dilation by 32% from baseline and 49% versus placebo, while reducing lipid peroxidation. A separate trial in healthy volunteers showed enhanced endothelium-dependent forearm dilation after just two weeks. In hypertensive patients, Pycnogenol reduced endothelin-1, a potent vasoconstrictor, while raising prostacyclin (a vasodilator), and allowed lower doses of nifedipine to control blood pressure.
Blood pressure. The data is mixed. A 2020 meta-analysis of 12 trials with 922 participants found pycnogenol reduced systolic BP by about 3.2 mmHg and diastolic BP by 1.9 mmHg, with larger effects in hypertensive subjects and longer interventions. A cardiometabolic meta-analysis of 24 RCTs also found small but consistent reductions in BP, fasting glucose, HbA1c, BMI, and LDL, alongside HDL increases. However, a separate PRISMA-compliant meta-analysis restricted to high-quality double-blind placebo-controlled trials found no significant BP effect. The honest read: don't take pine bark extract expecting it to replace antihypertensive medication. The vascular benefit is real but modest, and shows up most clearly in people whose vessels are already underperforming.
Skin and connective tissue. This is where the women's data is strongest. In a 12-week trial of 20 postmenopausal women given 75 mg/day, skin biopsies showed a 44% increase in hyaluronic acid synthase-1 (HAS-1) gene expression, a 29% increase in collagen type 1A1, and a 41% increase in collagen type 1A2. Skin elasticity improved 25%, hydration 8%, with the biggest gains in women who started with dry skin. The mechanism appears to be the procyanidins binding to and protecting collagen and elastin from MMP-mediated degradation, while simultaneously upregulating extracellular matrix synthesis. This is the same mechanistic family as what GHK-Cu does, just less potent and oral rather than injected.
Perimenopause and menopause. Two well-designed RCTs cover this. A 12-week Taiwanese RCT in 200 perimenopausal women found that 200 mg/day improved every climacteric symptom on the Women's Health Questionnaire and improved the LDL/HDL ratio. A later Japanese RCT in 170 perimenopausal women using a much lower dose (60 mg/day for 12 weeks) reduced the total Kupperman Index by 56% versus 39% on placebo, with significant improvements in hot flashes and sleep quality starting at week 4. Pycnogenol does not have estrogenic activity, which is the appealing part: the vascular relaxation it provides seems to do most of the heavy lifting on hot flashes (vasomotor symptoms are essentially episodes of dysregulated thermoregulation through dilated skin vessels), without touching the hormonal axis. This makes it a sensible option for women who can't or don't want to use HRT.
Menstrual pain and endometriosis. A 2007 dysmenorrhea RCT in 116 women and an open-label endometriosis trial both showed reductions in pain and analgesic use, with the endometriosis study showing a 33% reduction in symptoms over 48 weeks. The proposed mechanism is NF-κB inhibition, which downregulates COX-2 and the inflammatory cascade driving uterine cramping. Notably, five women in the endometriosis trial became pregnant during the study, which the authors attributed to its non-hormonal mechanism (unlike the GnRH agonist comparator, which causes a hypoestrogenic state and stops ovulation).
Erectile function in men. A 2023 meta-analysis of 3 RCTs in 184 men found significant improvements in IIEF erectile function scores, intercourse satisfaction, orgasmic function, and sexual desire when pycnogenol (around 80-120 mg/day) was combined with L-arginine aspartate (around 3 g/day). The mechanism is the same as everywhere else: better endothelial NO production. L-arginine is the substrate, pycnogenol activates the enzyme, and the cavernous tissue of the penis is exquisitely sensitive to NO availability. As a standalone, pycnogenol is less impressive for ED. As a stack with arginine, the effect is meaningful for mild to moderate cases.
Cognitive function. Mostly studied in older adults and ADHD. A network meta-analysis of botanical interventions for mild cognitive impairment ranked pycnogenol as the most effective intervention with a large effect size for cognitive function and activities of daily living. Working memory and spatial memory show the most consistent benefits, plausibly via better cerebral blood flow and reduced oxidative damage in the brain. In ADHD, an early RCT in 61 children showed reduced hyperactivity and improved attention at 1 mg/kg/day, and the larger phase III trial comparing pycnogenol to methylphenidate is still ongoing. Don't go in expecting a stimulant-like cognitive lift. The effect is more about structural support.
Joint pain and osteoarthritis. Three RCTs in mild to moderate knee OA have shown reduced pain and stiffness, with a 3-month trial of 150 mg/day producing a 56% reduction in pain on the WOMAC score. The mechanism is mechanistic NF-κB and COX-2 inhibition plus polyphenol metabolites concentrating in synovial fluid. A pre-surgical pilot study in severe OA patients showed that 200 mg/day for 3 weeks downregulated MMP3, MMP13, and IL-1β gene expression in cartilage cells, providing direct molecular evidence for the cellular effects.
Chronic venous insufficiency and varicose veins. Pycnogenol has consistent evidence for reducing leg swelling, heaviness, and pain in CVI, with an ex vivo study on vein segments showing that 3 months of 150 mg/day actually changed the mechanical properties of varicose veins, reducing passive dilation and improving recoil. This is a structural, slow effect rather than acute, and one of the better-evidenced uses for the compound.
Limitations of the evidence. Most of the strongest trials were funded or supported by Horphag Research, the company that owns the Pycnogenol trademark. Independent replications exist but are fewer. Effect sizes are typically modest. The Cochrane review was unable to draw firm conclusions for any chronic disorder due to heterogeneous trial quality. The compound is real and the mechanisms are real, but the marketing tends to overstate the magnitude. Generic non-Pycnogenol pine bark extracts (oligopin, flavangenol, and unbranded Chinese pine bark) have different procyanidin profiles and the data on them is much thinner, so the evidence here only really applies to Pycnogenol-grade material.
Dosage:
- General vascular and skin support: 50-100 mg/day, typically split into two doses with meals
- Higher therapeutic doses (osteoarthritis, hypertension, cognitive support, perimenopause): 100-200 mg/day, split into 2-3 doses
- Menstrual pain and endometriosis: 60 mg/day starting 7 days before menstruation and continuing through. Some protocols use 30 mg twice daily continuously across cycles
- Erectile dysfunction (men): 80-120 mg/day Pycnogenol stacked with 1.5-3 g/day L-arginine aspartate. The combination matters, neither component alone produces the same effect
- ADHD (children): 1 mg/kg/day
- Timing: Take with food. Polyphenol absorption is improved with a small amount of fat in the meal. Splitting the dose across the day gives more even plasma metabolite levels than a single dose
- Onset: Allow 4-6 weeks before judging effects. Vascular and skin changes accumulate. Menstrual pain effects show up by the second cycle. Hot flash improvements typically by week 4
- Cycling: Most studies run 8-12 weeks continuously. Long-term safety has been studied out to 30 months in some trials without issues. Cycling isn't required, though some people pause every few months to reassess whether they still need it
- Quality: The trial data applies to Pycnogenol specifically. If you buy generic pine bark extract, look for products that specify Pinus pinaster from the southwest French coast and standardize to roughly 70% procyanidins. Cheap generics from other pine species or other regions don't have equivalent evidence
Here's what you can expect:
In the first 2-3 weeks, most people feel nothing dramatic. Some notice slightly better leg circulation, less afternoon leg heaviness, or a vague sense of being less puffy. This isn't placebo, the vascular changes are slow because the compound works by improving how endothelial cells regulate themselves rather than acutely dilating vessels.
By weeks 4-8, the more noticeable effects show up. Women with perimenopausal symptoms typically report fewer and less intense hot flashes around week 4. Skin tends to look slightly more hydrated and elastic by week 8-12. Men using it with L-arginine for erectile function generally see meaningful improvement by month 2. Joint comfort in mild OA tends to build gradually rather than suddenly.
Things you probably won't notice: a stimulant-like cognitive lift, a sharp drop in blood pressure, anything that feels like a drug. If you go in expecting subjective fireworks, you'll be disappointed. The win with this compound is the structural improvements, vessels that work better, skin that holds onto more water, vasomotor symptoms that don't escalate, joints that complain less, that compound over months and years rather than weeks.
If nothing has changed by 12 weeks at an adequate dose (at least 100 mg/day for most uses), it probably isn't going to.
Side effects & risks:
- GI discomfort is the most common side effect, mild nausea, bloating, or stomach upset, occurring in roughly 2-5% of users. Take with food to minimize. Pooled safety data across 70+ clinical trials with 5,723 subjects shows an overall adverse event rate of 2.4%, dropping to 0.19% in healthy subjects
- Headache and dizziness occur in a minority of users, usually mild and transient
- Bleeding risk: Pycnogenol mildly inhibits platelet aggregation, similar to a low-dose aspirin effect. Stack with caution if you're on warfarin, clopidogrel, DOACs (apixaban, rivaroxaban), or high-dose fish oil. Stop at least 2 weeks before any planned surgery
- Blood pressure: shown to have a slight BP lowering effect
- Blood glucose: Pycnogenol can lower blood glucose modestly. If you're on metformin, sulfonylureas, or insulin, monitor more closely when starting. The effect is usually beneficial but stacking glucose-lowering interventions can cause hypoglycemia in sensitive individuals
- Autoimmune conditions: Some practitioners caution against use in MS, lupus, and rheumatoid arthritis on the theoretical grounds of immune stimulation. The evidence for clinically meaningful immune activation in humans is weak, and the anti-inflammatory effects (NF-κB, COX-2 inhibition) might actually be helpful in autoimmune conditions, but the data is inconsistent. If you have an autoimmune diagnosis, talk to your specialist before starting
- Pregnancy: Limited human safety data in the first and second trimesters. There's some evidence of safety in the third trimester (it's been studied for pregnancy-related leg pain and venous insufficiency), but the conservative position is to avoid in early pregnancy
- Breastfeeding: Insufficient data, avoid
- Drug interactions: Beyond the bleeding and glucose concerns above, no major interactions documented. Caution with immunosuppressants in transplant patients
- Quality concerns with non-Pycnogenol products: Generic pine bark extracts vary widely in procyanidin content and contaminants. The safety data is essentially all on Pycnogenol-grade material. If you use a generic, you're trading on inference rather than evidence
Blood markers
Blood pressure, baseline. The compound mildly lowers BP and you want a reference. Recheck at 8-12 weeks, particularly if you're using it for vascular support.
Fasting glucose and HbA1c, baseline if you're using it long-term or have any glucose dysregulation. Recheck at 3 months. The drop is usually modest (around 5-6 mg/dL fasting glucose, 0.3% HbA1c) but worth confirming.
hs-CRP, optional. As a polyphenol with NF-κB inhibition, pycnogenol tends to reduce systemic inflammation markers. Useful if you're tracking long-term anti-inflammatory effects.
For most people taking 50-100 mg/day for general vascular and skin support, no specific bloodwork is needed. The people who actually need baseline labs are those on antihypertensives, anticoagulants, glucose-lowering drugs, or anyone with an autoimmune diagnosis considering long-term use.
Sold as a dietary supplement in most countries without prescription.
Made with Bullet